You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 4, October 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (63)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cytosine Arabinoside (CA) and Other Nucleosides in Herpes Virus Infections

GERALD E. UNDERWOOD, PhD; CAROLYN A. WISNER, MS; SHELDON D. WEED

Arch Ophthalmol. 1964;72(4):505-512.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Certain inhibitors of normal deoxyribonucleic acid (DNA) synthesis have been found to be clinically effective antiviral agents. After the observation that idoxuridine (5-iodo-2'-deoxyuridine, IUdR, IDU) inhibited herpes simplex virus plaques in a cell culture system (Herrmann, 1961),1 it was reported that this agent was highly active in curing herpes simplex keratitis in rabbits (Kaufman, 1962)2 and in man (Kaufman et al, 1962).3 Subsequently, another pyrimidine nucleoside, 1-β-D-arabinofuranosylcytosine hydrochloride (cytosine arabinoside or CA) was shown to cure herpes keratitis in rabbits (Underwood, 1962)4 and in man (Kaufman and Maloney, 1963).5 Because of the potential importance of these agents in antiviral chemotherapy, we continued our work on CA and expanded our studies to include other pyrimidine arabinosides.

Materials and Methods

In Vivo.

—Previously described procedures (Underwood, 1962)4 used to produce experimental herpes simplex keratitis in rabbits were modified as follows. Two drops of 2% . . . [Full Text PDF of this Article]


Author Affiliations

Kalamazoo, Mich

Department of Virology Research, The Upjohn Company.


Footnotes

Submitted for publication March 23, 1964.

Preliminary report read before the Third International Symposium for Chemotherapy, Stuttgart, Germany, July 22-27, 1963.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.